Name: ADC THERAPEUTICS SA (ADCT) Stock
Brand: ADC THERAPEUTICS SA
Rating: 6 (3 reviews)

ADCT Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: The Motley Fool

ADC Therapeutics (ADCT) Earnings Call Transcript

7 days ago - By: Zacks Investment Research - Mentions: OBIO

ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates

7 days ago - By: ADC Therapeutics SA

ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update

9 days ago - By: Zacks Investment Research - Mentions: ALC MTD AKBA

Mettler-Toledo Q3 Earnings Top Estimates, Sales Decline Y/Y

10 days ago - By: Zacks Investment Research - Mentions: PTGX

Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates

13 days ago - By: Zacks Investment Research - Mentions: CSTL

Castle Biosciences, Inc. (CSTL) Reports Q3 Loss, Tops Revenue Estimates

3 months ago - By: Benzinga

Preview: ADC Therapeutics's Earnings

7 days ago - By: Benzinga - Mentions: OGN TACT IMDX QRHC ...

Earnings Scheduled For November 10, 2025

14 days ago - By: ADC Therapeutics SA

ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025

21 days ago - By: ADC Therapeutics SA

ADC Therapeutics to Present at November Investor Conferences

a month ago - By: Zacks Investment Research - Mentions: ZTS ALLO CMMB

Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain

a month ago - By: ADC Therapeutics SA

ADC Therapeutics Announces $60 Million Private Placement

2 months ago - By: ADC Therapeutics SA

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

3 months ago - By: ADC Therapeutics SA

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

3 months ago - By: ADC Therapeutics SA

ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025

3 months ago - By: Zacks Investment Research - Mentions: ALVO

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates

3 months ago - By: ADC Therapeutics SA

ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

3 months ago - By: Zacks Investment Research - Mentions: TELA

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: ETON

Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates

3 months ago - By: ADC Therapeutics SA

ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025

3 months ago - By: Zacks Investment Research - Mentions: ALNY

Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?

4 months ago - By: ADC Therapeutics SA

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

5 months ago - By: ADC Therapeutics SA

ADC Therapeutics Makes Grant to New Employee Under Inducement Plan

5 months ago - By: ADC Therapeutics SA

ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)

5 months ago - By: ADC Therapeutics SA

ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028

5 months ago - By: ADC Therapeutics SA

ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress

6 months ago - By: ADC Therapeutics SA

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

6 months ago - By: Yahoo Finance - Mentions: AMAT WMT ENTA ARCT ...

AMAT Earnings: Demand Holding Up So Far

6 months ago - By: ADC Therapeutics SA

ADC Therapeutics to Present at Upcoming Investor Conferences

6 months ago - By: Zacks Investment Research - Mentions: ARMP

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates

6 months ago - By: ADC Therapeutics SA

ADC THERAPEUTICS SA (ADCT) Stock News

ADCT Latest News, Press Relases and Analysis

ADC Therapeutics (ADCT) Earnings Call Transcript

ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates

ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update

Mettler-Toledo Q3 Earnings Top Estimates, Sales Decline Y/Y

Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates

Castle Biosciences, Inc. (CSTL) Reports Q3 Loss, Tops Revenue Estimates

Preview: ADC Therapeutics's Earnings

Earnings Scheduled For November 10, 2025

ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025

ADC Therapeutics to Present at November Investor Conferences

Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain

ADC Therapeutics Announces $60 Million Private Placement

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates

ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates

ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025

Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics Makes Grant to New Employee Under Inducement Plan

ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)

ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028

ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

AMAT Earnings: Demand Holding Up So Far

ADC Therapeutics to Present at Upcoming Investor Conferences

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates

ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update